Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Safety
Genstruct Announces New Collaboration with Pfizer in Drug Safety
March 8th, 2008
Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better understand large scale biology announced that it has entered into a Master Research Agreement with Pfizer designed to cover current and future collaborations. The first collaboration under this new agreement is in the area of preclinical drug safety, focusing initially on a systems biology analysis of underlying mechanisms of drug-induced liver injury. "This collaboration is a direct outcome of the success of more than 20 previous research and development projects with Pfizer," said Dr. Keith O. Elliston, president and CEO at Genstruct. "Over the past...
Source: Law & Health Weekly (2008-03-08)
|
